We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

30 hedge funds and large institutions have $5.42M invested in ImmuCell in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

15% more funds holding

Funds holding: 26 → 30 (+4)

8% more capital invested

Capital invested by funds: $5.03M → $5.42M (+$397K)

0.97% more ownership

Funds ownership: 12.67% → 13.64% (+0.97%)

Holders
30
Holders Change
+4
Holders Change %
+15.38%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$110K
2
PP
Prosperity Planning
Missouri
+$104K
3
CAM
Cresset Asset Management
Illinois
+$26.5K
4
EFS
Essex Financial Services
Connecticut
+$17.5K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$16.4K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$35.7K
2
OMC
Overbrook Management Corp
New York
-$17.4K
3
Renaissance Technologies
Renaissance Technologies
New York
-$17.3K
4
PCM
Perritt Capital Management
Illinois
-$2.11K
5
Northern Trust
Northern Trust
Illinois
-$188
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.05M – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$633K -$17.3K -2,662 -2%
BL
3
Bleichroeder LP
New York
$524K – – –
CAM
4
Cresset Asset Management
Illinois
$518K +$26.5K +4,080 +4%
Morgan Stanley
5
Morgan Stanley
New York
$365K -$35.7K -5,500 -7%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$333K +$16.4K +2,519 +4%
SRC
7
Shufro Rose & Co
New York
$319K – – –
EFMC
8
Empire Financial Management Company
New York
$215K +$273K +42,000 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$196K – – –
OMC
10
Overbrook Management Corp
New York
$168K -$17.4K -2,675 -8%
SFS
11
Strategic Financial Services
New York
$160K – – –
PCM
12
Perritt Capital Management
Illinois
$152K -$2.11K -325 -1%
HighTower Advisors
13
HighTower Advisors
Illinois
$110K – – –
Citadel Advisors
14
Citadel Advisors
Florida
$87.4K +$110K +16,962 New
BlackRock
15
BlackRock
New York
$82.2K +$3.16K +486 +3%
PP
16
Prosperity Planning
Missouri
$81.8K +$104K +16,000 New
WE
17
Wealth Effects
Massachusetts
$80.1K +$110 +17 +0.1%
FHA
18
Flagship Harbor Advisors
Massachusetts
$72.7K – – –
EFS
19
Essex Financial Services
Connecticut
$70K +$17.5K +2,700 +25%
Northern Trust
20
Northern Trust
Illinois
$63.4K -$188 -29 -0.2%
MA
21
Minerva Advisors
Pennsylvania
$61.1K – – –
HPC
22
HM Payson & Co
Maine
$41.9K – – –
TRCT
23
Tower Research Capital (TRC)
New York
$12K +$6.88K +1,059 +83%
Bank of America
24
Bank of America
North Carolina
$10.4K -$39 -6 -0.3%
UBS Group
25
UBS Group
Switzerland
$9.18K +$1.92K +296 +20%
1
2

ICCC Hedge Fund Activity: Q1 2023 in Review

30 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2023, worth a combined $5.42M — up 7.9% from $5.03M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ICCC positions and 0 closed out — a net gain of 4 holders — while 8 added to existing stakes and 6 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $110K. The largest seller was Morgan Stanley, cutting an estimated $35.7K.

  • 30 institutional investors held ImmuCell (ICCC) as of Q1 2023, up from 26 in Q4 2022.
  • Funds reported $5.42M of ImmuCell stock for Q1 2023, up 7.9% quarter-over-quarter.
  • 4 funds opened new ImmuCell positions in Q1 2023 and 0 closed out, a net change of +4 holders.
  • The largest ImmuCell buyer in Q1 2023 was Citadel Advisors, an estimated $110K added.
  • The largest ImmuCell seller in Q1 2023 was Morgan Stanley, an estimated $35.7K sold.

Based on aggregated 13F filings for Q1 2023.